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The spleen plays an important role in host-protective
responses to bacteria. However, the cellular dynam-
ics that lead to pathogen-specific immunity remain
poorly understood. Here we examined Listeria
monocytogenes (Lm) infection in the mouse spleen
via in situ fluorescence microscopy. We found that
the redistribution of Lm from the marginal zone
(MZ) to the periarteriolar lymphoid sheath (PALS)
was inhibited by pertussis toxin and required the
presence of CD11c+ cells. As early as 9 hr after
infection, we detected infected dendritic cells in the
peripheral regions of the PALS and clustering of
Lm-specific T cells by two-photon microscopy. Per-
tussis toxin inhibited both Lm entry into the PALS
and antigen presentation to CD8+ T cells. Our study
suggests that splenic dendritic cells rapidly deliver
intracellular bacteria to the T cell areas of the white
pulp to initiate CD8+ T cell responses.
INTRODUCTION
The spleen is a highly structured lymphoid organ consisting of
three main compartments: the red pulp (RP) where red blood
cells are captured and recycled, the marginal zone (MZ) contain-
ing marginal zone B cells and phagocytes positioned along the
marginal sinus, and the white pulp (WP) where the majority of
T cells and B cells reside (Mebius and Kraal, 2005). As microbes
enter the marginal sinus of the spleen, they come in contact with
a variety of splenic phagocytes, including macrophages, den-
dritic cells (DCs), and granulocytes (Kraal, 1992). DCs play an im-
portant role in carrying antigen from peripheral tissues to drain-
ing lymph nodes to trigger the adaptive immune response
(Angeli and Randolph, 2006); however, an analogous picture
for how antigen transport and presentation takes place in the
spleen is lacking. Experiments that use low-dose clodronate-li-
posome treatment to selectively deplete marginal zone macro-
phages (MZM) showed that these cells were not required for
adaptive immunity to Listeria monocytogenes (Lm) (Aichele
et al., 2003). An important role for DCs in immunity to Lm
infection was more formally demonstrated via the CD11c-DTR476 Immunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc.system to deplete DCs (Jung et al., 2002; Muraille et al., 2005;
Neuenhahn et al., 2006). The issue of whether bacterial antigen
transport to the periarteriolar lymphoid sheath (PALS) of the
spleen is required for antigen presentation to T cells has been
raised by others (Muraille et al., 2005; Kursar et al., 2005) but
has not been investigated directly.
To investigate how antigen presentation occurs in the spleen,
we used the Lm infection model. Lm is a Gram-positive intracel-
lular bacterium widely used to study innate and adaptive immu-
nity in mice (Mackaness, 1962; Pamer, 2004; Unanue, 1997).
After intravenous (i.v.) injection, Lm infects the liver and spleen,
proliferates in these tissues for several days, and is eventually
cleared by Lm-specific T cell responses. Mice that survive Lm
challenge develop long-lasting CD8+ T cell immunity (Busch
et al., 1998; Lauvau et al., 2001; Shedlock and Shen, 2003;
Sun and Bevan, 2003). Although T cell responses to Lm infection
have been studied extensively, only recently has the impact of
tissue structure on Lm pathogenesis and development of host
responses been examined in situ (Khanna et al., 2007).
Here, we provide evidence that DCs in the spleen transport
bacteria from the MZ to the PALS for antigen presentation to
T cells, analogous to their role in carrying antigens from periph-
eral tissues to draining lymph nodes. As early as 9 hr after infec-
tion, we observed the clustering of Lm-specific T cells in the
PALS by two-photon (2P) microscopy, indicating that antigen
recognition occurs rapidly in the spleen. Preventing the entry
of Lm into the PALS by pretreating mice with pertussis toxin
(PTx) inhibited both the progression of Lm infection and the initi-
ation of antigen presentation to CD8+ T cells.
RESULTS
PTx Treatment Inhibits Lm Entry into PALS
We quantitatively examined the tissue distribution of bacteria
during splenic infection. Lm was injected i.v. into BALB/c mice,
and at different times after infection, spleen cryosections were
stained with antibodies to Lm and B220 andwith phalloidin (Mur-
aille et al., 2005) to identify the major spleen compartments
(Figure S1 available online). Lm redistributed dramatically from
MZ and RP to the PALS over the first 24 hr of infection (Figures
1A and 1B), consistent with previous histological studies
(Conlan, 1996; Muraille et al., 2005). Initially, bacteria were found
primarily in the MZ (65%) and RP (30%) (2 hr, Figures 1A and
1C). Lm was not observed in the PALS before 6 hr but was
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24 hr, the distribution of Lmwas reversed and the vastmajority of
bacteria were located in the PALS of the WP (70%), with some
bacteria (20%) remaining in the MZ and RP (Figures 1B and
1C).
Soluble substances (75 kD) can flow directly from the MZ
into the white pulp through a conduit network (Mebius and Kraal,
2005). Although bacteria are presumably too large to access the
PALS via this conduit network, we examined the possibility that
Lmmight alter conduit permeability and flow directly into the WP
to initiate PALS infection. First, we injected a large number of 1
mm fluorescent beads (108 or 1000 times more than the Lm
Figure 1. PTx Prevents Lm Translocation to
the PALS andDecreasesCFUs in the Spleen
(A) Spleen sections of mice 0.5 hr after infection
with 107 Lm. Cryosections were stained with phal-
loidin-Alexa350 (blue), Lm antibody (green), and
anti-B220-PE (red). Lower panels show magnified
regions (white squares in upper panels). Scale bar
represents 50 mm.
(B) Spleen sections of mice 24 hr after infection
with 105 Lm. At 24 hr, many Lm are observed in
the PALS area and few in the MZ and RP. Scale
bar represents 50 mm.
(C) Quantification of Lmdistribution in the spleen at
0.5hr (blackbar) and24hr (whitebar) after infection
(10 pooled nonoverlapping images from 2 mice).
The splenic compartments: RP, red pulp; MZ,
marginal zone; B, B cell follicle; and PALS, T cell
area were separated as described in Figure S1.
(D andE)Spleen sections of PTxpretreatedmiceat
0.5 hr (D) and 24 hr (E) after infection. Scale bars
represent 50 mm. Lower panels showmagnified re-
gions (white squares in upper panels).
(F) Lm distribution in the spleen of PTx-pretreated
mice at 0.5 hr (black bar) and 24 hr (white bar) after
infection (10pooled nonoverlapping images from2
mice).
(G) CFU per spleen in PTx-untreated mice (black
bar) and PTx-pretreated mice (white bar) at 0.5 hr
to 24 hr after infection with Lm (two separate ex-
periments, n = 5 to 7 mice per group). The p value
(0.0025) was calculated with a two-tailed Mann-
Whitney U-test.
dose) and analyzed their distribution in
the absence of infection. Beads were
found exclusively in the MZ and RP at
2 hr and only a few entered the PALS at
24 hr (Figures S2A and S2B). Next we co-
injected high molecular weight dextran
and Lm to determine whether infection al-
ters access to the WP (Figure S2C). Dex-
tran remained outside the PALS 2 hr after
coinjection with Lm, indicating that infec-
tion did not markedly affect conduit per-
meability over this time. We also injected
0.5 mm beads (approximately the diame-
ter of Lm) 4 hr after infection and found
that the beads localized to the MZ and
RP and did not enter the PALS.Moreover,
live Lm in the spleen is insensitive to the cell-impermeable anti-
biotic gentamicin within minutes of i.v. challenge (Figure S2D),
suggesting that bacteria are intracellular and not free to enter
the PALS independently.
We postulated that Lm entry into the PALS requires the migra-
tion of host cells. To test this hypothesis, we treated mice with
500 ng pertussis toxin (PTx) i.p. and then examined Lm tissue
distribution at 0.5 and 24 hr after Lm challenge (Figures 1D and
1F). PTx has been shown to block G protein-mediated (Gai) che-
mokine receptor signaling and to inhibit leukocyte trafficking (Ato
et al., 2004; Huang et al., 2007; Itano et al., 2003; Okada and
Cyster, 2007). PTx treatment did not change the initial tissueImmunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc. 477
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Immunofluorescence images of Lm and various host cell markers in spleen at 12 hr (A) and 24 hr (B) after infection. Cryosections were stained for B220 (blue), Lm
(green), and the antibodies to host cell markers as indicated in the figure. Scale bars represent 100 mm. Lmwas associatedwith CD11b+ and CD11c+ cells at 12 hr
in the PALS (white arrows) but not with MOMA-1+ metallophilic marginal zone macrophages. At 24 hr after infection, bacteria shown as yellow spots in the image
associated with CD11b+ cells and CD11c cells. Lm in MOMA-1+ cells is indicated with white arrows. The lower left inset shows a magnified region in the white
square. Images are representative of at least three independent experiments.distribution or the amount of Lmdetected in spleen sections (Fig-
ures 1D and 1F); however, it profoundly inhibited Lm entry into
the PALS (99% decrease) 24 hr after challenge (Figures 1E
and 1F). The early trapping and growth of Lm appeared normal
after PTx treatment because Lm colony-forming units (CFU) in
PTx-treated and control mice were similar for up to 6 hr
(Figure 1G), and the initial cellular distribution of Lm appeared
unaffected by PTx (data not shown). At 24 hr after infection,
when Lm proliferation takes place primarily in the PALS, the
number of viable bacteria was markedly reduced (90% de-
creased) compared with untreated mice (Figure 1G). Thus, the
reduced number of bacteria in the PALS after PTx treatment is
primarily due to inhibition of bacterial entry and not due to effects
on Lm capture or growth during the early stage of infection.
Spleen Remodeling in Response to Lm Infection
We examined the distribution of host cells in the spleen before
and after infection to identify the cell types that migrate to the
PALS and possibly transport Lm. In uninfected mice, host cell
populations were observed in their expected locations in the
spleen (Figure S3A). At 12 hr, Lm colocalized with CD11b+ cells
in the PALS and CD11c+ cells primarily near the bridging
channel, a structure that connects the WP to the RP (Figure 2A;
Metlay et al., 1990; Mitchell, 1973). Metallophillic marginal zone
macrophages (MOMA-1+) (Figure 2A; Kraal and Janse, 1986)
had not entered the PALS in substantial numbers at this time.
By 24 hr after infection, the number of MOMA-1+, CD11b+, and
CD11c+ cells had increased in the PALS (Figure S3B). In con-
trast, F4/80+ (RP macrophages), MARCO+ (Elomaa et al.,
1995), and ER-TR9+ (MZM) (Dijkstra et al., 1985) remained in
their expected locations, similar to uninfected controls (Figures478 Immunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc.S3A and S3B). At 24 hr, we found extensive Lm growth in the
PALS and many CD11b+ cells contained Lm at foci of infection
(Figure 2B). Bacteria were also found in MOMA-1+ (Figure 2B,
arrowhead) and CD11c+ cells, although in lower numbers than
observed for CD11b+ cells.
Lm Entry into PALS Requires CD11c+ Cells
To determine which cells are involved in Lm invasion of the
PALS, we took advantage of the different recovery kinetics of
splenic macrophages and DCs after clodronate-liposome-medi-
ated depletion (van Rooijen et al., 1989) and looked for an asso-
ciation between host-cell recovery and Lm infection of the PALS.
The injection of clodronate liposomes ablated splenic macro-
phages by day 2 after treatment and these cells remained de-
pleted for at least 1 week (Figure S4), as reported previously
(van Rooijen et al., 1989). In our hands, clodronate liposomes
also depleted CD11c+ cells by day 2, but these cells recovered
substantially by day 6 (Figure S4). Similar DC recovery kinetics
were observed in work with the CD11c-DTR transgenic system
(Jung et al., 2002) and is consistent with the high turn-over rate
(3 days) reported for splenic CD11c+ cells (Kamath et al.,
2000). Notably, CD11b+ cells were not depleted by clodronate li-
posome treatment and appeared to slightly increase in number
by day 2 (Figure S4). The CD11b+ cells identified in our sections
are most likely granulocytes (95% are F4/80 and Gr-1+, data
not shown) and recently recruited inflammatorymonocytes or tu-
mor necrosis factor-alpha and inducible nitric oxide synthase-
producing DCs (TipDCs) (Serbina et al., 2003).
To determine which cells play a role in the translocation of Lm
to PALS, we depleted splenocytes with clodronate liposomes,
then infected mice with Lm on either day 2 or 6 after clodronate
Immunity
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ence of Lm (Figure 3A). In mice infected on day 2, when both
macrophages and CD11c cells were depleted, the vast majority
of bacteria (70%) were found in the MZ (Figure 3B, left) and
<10% of the total Lm signal was present in the PALS, compared
to 70% in infected mock-depleted controls (Figure 1B). In
mice infected on day 6 after clodronate treatment, when
CD11c+ cells had recovered but macrophages had not, wide-
spread Lm growth in the PALS was observed (Figure 3B, right),
suggesting that DCs play an important role in the progression of
Lm infection to the PALS. Because CD11b+ cells are present on
day 2 when Lm remains in the MZ, these cells do not play a dom-
inant role in the initial entry of Lm into the PALS, but most likely
follow the bacteria into the PALS once it becomes infected. The
close association between DC appearance and PALS infection
was confirmed by means of CD11c-DTR mice (Jung et al.,
2002) and a similar cell depletion and recovery approach
(Figure S5).
The Arrival of Infected DCs in the PALS Initiates Antigen
Presentation
The precise location of T cell priming in the spleen is unknown.
T cells are most abundant in the PALS; however, they are also
Figure 3. CD11c+ Recovery after Clodro-
nate-Liposome Depletion Correlates with
PALS Infection
(A) Outline of the experimental protocol. Clodro-
nate liposomes were prepared as described previ-
ously and administered to deplete splenocytes 2
or 6 days prior to infection. Mice were infected
with 105 Lm and sections were stained for
CD11c (red) and Lm (green) to assess the degree
of PALS infection 24 hr later (asterisk).
(B) Spleen cryosections from clodronate-treated
mice (top) infected on day 2 (left) or day 6 (right).
Scale bars represent 200 mm. Dashed lines indi-
cate MZ regions based on phalloidin staining
(blue). Quantitative analysis (bottom) of Lm distri-
bution in splenic compartments. Data are repre-
sentative of two or more independent experi-
ments.
found in the RP and MZ and antigen pre-
sentation could occur in these compart-
ments as well. Based on our depletion
and recovery results, we speculated that
the entry of infected DC into the PALS
triggers antigen presentation to T cells.
To test this hypothesis, we used Lm-spe-
cific CD8+ T cells from WP11.12 TCR
transgenic mice (Mercado et al., 2000;
Wong and Pamer, 2003) to detect antigen
presentation in situ. BALB/c mice re-
ceived 4 3 106 adoptively transferred
CFSE-labeled WP11.12 CD8+ T cells
and cells were allowed to home (4–8 hr)
before mice were infected with Lm. At
various times after infection, spleen cryo-
sections were examined by immunofluo-
rescence microscopy for T cell clustering as evidence of antigen
recognition (Figure 4A). In the absence of infection (0 hr),
WP11.12 T cells were distributed evenly in the PALS area and
appeared bright and small, consistent with a resting phenotype.
As early as 9 hr after infection, manyWP11.12 T cells clustered in
the PALS near the bridging channel (9 hr, inset), indicating that
antigen presentation had begun. At 21 hr after infection, clusters
had increased in size andmoved into the center of the PALS, and
by 41 hr, T cells had dissociated and large activated CFSElo
WP11.12 T cells were distributed evenly through out the PALS
(41 hr, inset). We could not detect WP11.12 T cell clusters in
the MZ or RP over this time frame.
Infected CD11c+ cells were often associated closely with
WP11.12 T cell clusters (Figure 4B, CD11c). These Lm-contain-
ing cells were MHC II+ and showed characteristic DC morphol-
ogy (Figure 4B, MHCII). Although CD11b+ cells were found
near T cell clusters, they were not MHC II+ and did not localize
to the center of clusters (data not shown). Lm was typically ob-
served in the center of T cell clusters in cryosections
(Figure 4B) and in spleen explants via GFP-labeled bacteria
and 2Pmicroscopy (Figure 4C).We did not find T cell clusters as-
sociated with MARCO+ or MOMA-1+ macrophages during the
first 41 hr of infection (data not shown). Thus, DCs appear toImmunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc. 479
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and Location during Lm Infection in the
Spleen
(A) CFSE-labeled WP11.12 CD8+ T cells (4 3 106
cells, green) were adoptively transferred into
mice before infection with 105 Lm. Spleens were
harvested at the indicated times and stained with
B220 to identify B cell follicles (red). White dashed
lines indicate the edge of the white pulp based on
phalloidin staining (blue). Scale bars represent
200 mm. Zoomed images (from white boxes) of
WP11.12 cells in the PALS at 9 hr and 41 hr. Scale
bars in zoomed images represent 50 mm. Figures
are representative of more than five images per
group from at least three independent experi-
ments.
(B) Lm-specific T cell clusters (WP11.12, blue),
CD11c+ cells (red), and Lm (green) at 9 hr after in-
fection. Scale bar represents 100 mm. Insets show
zoomed in views of T cell clusters (blue) and
CD11c or MHC II staining (red). Scale bar in
zoomed image represents 20 mm. Images are rep-
resentative of at least two independent experi-
ments.
(C) 3D image of a representative Lm-specific T cell
cluster (blue) 10 hr after infection with 105 GFP-
expressing Lm (cyan). BALB/c mice received 2 3
106 CMAC-labeled WP11.12 cells. Scale bar rep-
resents 20 mm.be the primary APC type interacting with CD8+ T cells in the early
stages of infection.
Lm Transport to PALS Is Required for Antigen
Presentation
We performed time-lapse 2P microscopy (Germain et al., 2006;
Miller et al., 2002) to determine whether blocking Lm entry into
the PALS with PTx would inhibit antigen presentation. Spleens
were removed, secured to plastic coverslips with veterinary tis-
sue adhesive, cut longitudinally with a vibrotome to expose the
white pulp regions, and placed in warm oxygenated medium
for imaging.
In uninfected mice, Lm-specific WP11.12 T cells moved ran-
domly in the PALS with a median track velocity of 5 mm
min1 and amotility coefficient of60 mm2min1, similar to poly-
clonal CD8+ T cells (Figures 5A and 5B; see also Movie S1).
T cells migrated randomly and did not form clusters, similar to
the T cell behavior previously observed in lymph nodes (Miller
et al., 2002). However, the median T cell velocities measured in
spleen explants were lower than mean values published for
T cell migration in lymph nodes of 12 mm/min (Miller et al.,
2002). Our explanation for this discrepancy is that the decreased
frame rate used in our current study (2 images/min versus 4–6
images/min in previous studies) smoothes the characteristically
large fluctuations in velocity associated with T cell motility and
reduces the measured peak velocity in the data set. A decrease
in peak velocity consequently yields a lower median velocity be-
cause themedian is calculated from the velocity range. To inves-480 Immunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc.tigate this issue further, we imaged T cells in explanted lymph no-
des with our acquisition protocol and found slightly higher
median T cell velocity (7–8 mm/min, data not shown), suggest-
ing that T cell motility is slightly slower in the spleen.
In infected mice, WP11.12 T cells showed significantly re-
duced velocity and motility (Figures 5A and 5B; see also Movie
S2). Lm-specific T cells formed large aggregates in the PALS
containing approximately 15 cells per cluster (Figures 4C and
5B). Occasionally, a few polyclonal CD8+ T cells interacted tran-
siently with theWP11.12 clusters, but most remained motile with
no substantial reduction in velocity and motility (Figure 5B), indi-
cating that cluster formation is antigen specific. Because the
high antigen-specific T cell frequencies in adoptive transfer ex-
periments can alter the kinetics and differentiation of responding
T cells, we performed a limited number of experiments by using
as few as 500,000 adoptively transferred Lm-specific T cells
(Figure S6). Under these conditions we observed similar antigen
recognition kinetics and clustering behavior (4 cells per cluster;
Figure S6; Movie S3).
When mice were pretreated with PTx to prevent Lm transport
to the PALS, the clustering of bacteria-specific T cells was in-
hibited (Figures 5A and 5B; see also Movie S4). The lack of clus-
tering was not due to the inhibition of T cell motility, because
adoptively transferred polyclonal T cells moved with comparable
velocity and motility in PTx-pretreated and untreated mice (Fig-
ures 5A and 5B) in our experimental protocol. When PTx was
given 2 hr after T cell adoptive transfer, we observed de-
creased T cell motility (data not shown), similar to the results of
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capable of inhibiting T cell migration in the spleen, it does not re-
main active 24 hr after injection. As a further control for potential
PTx effects on T cells, we administered PTx after Lm had entered
the PALS (9–10 hr after infection). Lm-specific and polyclonal
T cells were transferred and 2 hr later spleen explants were ex-
Figure 5. PTx Inhibits Antigen Presentation to
Lm-Specific CD8+ T Cells
(A) 2P time-lapse image sequences of T cells 9 hr after
infection in explanted spleens. Lm-specific WP11.12
T cells (4–6 3 106, blue) and polyclonal CD8+ T cells
(5–7 3 106, red) were transferred into naive mice or PTx-
pretreated mice. 6 hr later, mice were infected with
105 Lm. Representative WP11.12 cell tracks are shown
(yellow lines). Scale bar represents 20 mm.
(B) WP11.12 and polyclonal CD8+ T cell (pCD8) tracks
were analyzed for velocity, motility, and cluster formation.
Bars show means for each data group (1–6). Data are rep-
resentative of at least three independent experiments.Me-
dian velocity: group 1 versus 2, p > 0.05; 3 versus 4, p <
0.001; 5 versus 6, p > 0.05; 2 versus 4, p < 0.001; 2 versus
6, p > 0.05; 3 versus 5, p > 0.05; 4 versus 6, p < 0.001. Mo-
tility coefficient: group 1 versus 2, p > 0.05; 3 versus 4, p <
0.001; 5 versus 6, p > 0.05; 2 versus 4, p < 0.001; 2 versus
6, p < 0.05; 3 versus 5, p > 0.05; 4 versus 6, p < 0.001.
Cluster size: group 1 versus 2, p > 0.05; 3 versus 4, p >
0.05; 5 versus 6, p > 0.05; 2 versus 4, p < 0.05; 2 versus
6, p > 0.05; 4 versus 6, p < 0.01. p values were calculated
with the Kruskal-Wallis test.
(C) 5–7 3 106 CFSE-labeled WP11.12 T cells were adop-
tively transferred into mice. T cell proliferation was mea-
sured in uninfected control mice and on day 3 after infec-
tion in three experimental groups: mice infected with 104
Lm, mice pretreated with PTx then infected with 104 Lm,
and mice pretreated with PTx and infected with 5 3 104
Lm (a five times higher dosewas used in this group in order
to compensate for the reduced Lm burden in the PTx-
treated mice). PTx reproducibly inhibited Lm-specific
T cell proliferation but did not completely block it. The
mean ± SD of three mice in one representative experiment
is shown. Data are representative of at least three inde-
pendent experiments with similar results.
amined by 2P microscopy. Once Lm transport
had occurred, PTx treatment no longer inhibited
WP11.12 cluster formation whereas control
T cells showed normal motility (Movie S5). Al-
though Lm could be detected in the MZ and
RP of PTx-treated mice (Figure 1D), we did not
detect T cell clusters in these regions (Figure 4;
2P data not shown).
As a second indicator of antigen presenta-
tion, we measured adoptively transferred
WP11.12 T cell proliferation by CFSE dilution
assay. PTx pretreatment reproducibly de-
creased the number of proliferating WP11.12
T cells compared to untreated controls
(Figure 5C). Decreased T cell proliferation was
also observed when a larger inoculum of Lm
was used to compensate for the lower Lm
CFU present in PTx-treated mice at 24 hr
(Figure 5C, bottom). We also assessed the ef-
fects of PTx treatment on antigen presentation in vitro by using
the Ova-specific OT1 transgenic T cells. DC were isolated from
spleen and treated in vitro with 20 and 200 ng/ml Ptx for 2 hr
(200 ng/ml is roughly equivalent to the in vivo dose of 500 ng
per mouse.). After PTx treatment, DCwere fed OVA or OVA-con-
jugated beads in the presence of LPS for 4 hr before cocultureImmunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc. 481
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tigen presentation with either OVA or OVA-conjugated beads
(Figure S7).
Next, we examined the effect of PTx treatment on the behavior
of resident DCs and macrophages by using 2P microscopy.
CD11c-YFP mice (Lindquist et al., 2004) were given a single
i.p. injection of PTx (500 ng) 1 day before the spleens were har-
vested and prepared for time-lapse imaging. Fluorescent beads
were injected i.v. to define the MZ and distinguish YFP+ MZMs
(containing many beads) from DCs (containing few or none) in
our analysis. In mock-treated mice, DCs showed active probing
behavior and appeared to migrate randomly in the PALS and
bridging channel with a median velocity of 6.3 mm/min (Movie
S6 and Figure 6). We also observed DCs migrating to and from
the MZ-PALS border. In Ptx-treated mice, DC probing behavior
was lost and cell velocity was significantly reduced (p < 0.001,
Figure 6. PTx Effects on DC and Macrophage Motility In Situ
Spleen explants were prepared (as described in Experimental Procedures)
from CD11c-YFP mice (Lindquist et al., 2004) that received PBS or 500 ng of
PTx 24 hr earlier. Spleen explants were imaged with 2P microscopy and cell
motility analyzed (see Experimental Procedures for details).
(A) Median track velocity.
(B) Motility coefficient of DCs and macrophages (Mac) was determined. PTx
significantly reduces DC motility and probing behavior but has no observable
effect on macrophages, which are normally not motile in our time-lapse im-
ages. The data were generated from three independent experiments per
group. One-way analysis of variance with Newman-Keuls Multiple Compari-
son post test was performed.
The p values for (A) are: Mac PTX versus DC_Control, p < 0.001; Mac_PTX ver-
sus DC_PTX, p < 0.001; Mac_PTX versus Mac_Control, p > 0.05; Mac_Control
versus DC_Control, p < 0.001; Mac_Control versus DC_PTX, p < 0.001;
DC_PTX versus DC_Control, p < 0.001. The p values for (B) are: Mac_PTX
versus DC_Control, p < 0.001; Mac_PTX versus DC_PTX, p > 0.05; Marc_PTX
versus Mac_Control, p > 0.05; Mac_Control versus DC_Control, p < 0.001;
Mac_Control versus DC_PTX, p > 0.05; DC_PTX versus DC_Control, p <
0.001.482 Immunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc.Movie S7 and Figure 6A). Although DCs were able to move
slightly, they exhibited little displacement over time and their mo-
tility coefficient was significantly reduced (p < 0.001, Figure 6B).
PTx treatment did not appear to alter the behavior of MZMs and
these cells remained essentially nonmotile over the time frame of
our imaging experiments (Movies S6 and S7 and Figure 6).
During sublethal Lm infection, T cell responses reduce the
bacterial burden 5–7 days after challenge and over 2 weeks, re-
sulting in the eradication of Lm. We tested whether blocking Lm
entry to the PALS with PTx affected the survival of mice to pri-
mary infection. Although PTx-treated mice had reduced CFU in
the spleen at 24 hr (Figure 1E), these mice could not control
Lm at later times and succumbed to infection (Figure 7). Because
endogenous lymphocytes are presumably exposed to PTx in
these experiments, it is unclear whether PTx affects survival by
inhibiting antigen presentation to CD8+ T cells or by inhibiting
cell effector functions. Moreover, the decreased survival of
PTx-treated mice could be due to the defective recruitment of
TipDCs, which have been shown to be required to control Lm
infection (Serbina et al., 2003).
DISCUSSION
In this study, we sought to determine whether DCs play a role in
transporting bacteria from the MZ to the PALS, analogous to
their role in carrying antigens from peripheral tissues to draining
lymph nodes. The location and kinetics of bacterial antigen pre-
sentation in the spleen are poorly defined. 2P microscopy al-
lowed us to assess antigen presentation in situ by quantifying
changes in the motility and clustering of Lm-specific T cells. In
the Lm infectionmodel, we did not find evidence of bacteria-spe-
cific CD8+ T cell responses in either the MZ or RP during the first
2 days of infection, suggesting that the PALS is the primary com-
partment where CD8+ T cells first recognize antigen. In our study,
we focused on the earliest detectable stages of antigen presen-
tation. However, work with MHC class I tetramer staining in situ
Figure 7. PTx Treatment Decreases the Survival of Mice after Lm
Infection
Mice were pretreated with PTx i.p. then challenged with 5 3 103 Lm EGD.
Survival was followed for 21 days. p values were calculated with a log rank
test (n = 10 mice per group). Black line, infected mice; red line, PTx-treated,
infected mice; blue line, PTx-treated, uninfected mice. Ptx treatment severely
compromised the host responses to Lm infection.
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der andMZ beginning 3 days after infection (Khanna et al., 2007),
suggesting that other regions of the spleen are involved at later
times. Moreover, T cell responses were detected in the splenic
RP after an i.v. injection of soluble peptide (Odoardi et al.,
2007), demonstrating that antigen presentation can occur out-
side the PALS. To what extent immune responses to viruses
and other bacteria are initiated in distinct splenic compartments
is an interesting question. If the location of antigen presentation
is dependent on the type and route of infection, then the tissue
microenvironment where antigen presentation occurs might play
a pivotal role in shaping the character of the pathogen-specific
immune response.
Our primary evidence linking Lm transport to antigen presen-
tation is that PTx treatment inhibits both the entry of bacteria
into the PALS and the recognition of bacterial antigen. We
used 2P imaging to analyze Lm-specific T cell responses and
found that PTx inhibited the clustering and arrest of T cells only
if administered before Lm gained entry into the PALS. We found
that PTx treatment after T cell adoptive transfer does indeed de-
crease T cell velocity in the spleen, as observed by others (Huang
et al., 2007; Okada and Cyster, 2007). However, in our protocol,
the inhibition of antigen presentation by PTx is due to blocking
APCmigration and not due to inhibition of T cell motility, because
adoptively transferred T cells appear unaffected (i.e., motility
was identical in PTx-treated and untreated mice). Moreover,
when we gave PTx 2 hr before T cell transfer, control T cells
showed normal motility and Lm-specific T cells clustered nor-
mally. Our explanation is that PTx is rapidly consumed in vivo
and does not affect T cells transferred subsequently.
Our 2P microscopy experiments revealed that PTx markedly
inhibited DC motility in the spleen. Previously, PTx was reported
to inhibit DC homing to the thymus, but not the spleen (Bonasio
et al., 2006). Although DCs may enter the spleen passively from
the circulation, DC migration into the PALS appears to require
chemokine receptor signaling, as suggested by studies with
CCR7-deficient knockout mice (Kursar et al., 2005).
There were no statistical differences in CFU counts per spleen
between Ptx-treated mice and untreated controls during the first
6 hr of infection, suggesting that PTx treatment did not interfere
with the initial trapping of Lm. However, the increased CFUs in
PTx-treated mice at 24 hr indicated that the infection does not
progress normally and that Lm proliferation in the PALS is in-
hibited. Although PTx could interfere with actin rearrangements
involved in the host cell invasion by Lmor cell-cell spread, we be-
lieve that the main effect of PTx is on splenocyte migration be-
cause others have shown that ActA-deficient Lm were capable
of invading and proliferating in the PALS, albeit at a lower level
(Muraille et al., 2005). Moreover, we performed histological ex-
periments to examine the impact of PTx pretreatment on Lm
capture and found that the cellular distribution and amount of
bacteria captured was similar to untreated control mice.
Neuenhahn et al. (2006) concluded that viable Lm was found
exclusively in CD8a+ DCs 3 hr after infection and proposed
that these DCs were responsible for the initial trapping of live
Lm in the spleen. Our results extend on previous work by show-
ing that DCs facilitate Lmentry into the PALS and that this entry is
required for efficient antigen presentation. It is noteworthy that
we found infected MOMA-1+ macrophages and CD11b+ cellsin the PALS at 24 hr, but did not find CD8+ T cell clusters asso-
ciated with these cells, and therefore their role in antigen presen-
tation remains unclear. A variety of splenic phagocytes capture
Lm initially, but bacteria expand transiently in DCs, suggesting
that DCs may support Lm growth in vivo (unpublished observa-
tions). It is possible that the transient proliferation of bacteria in
DCs is advantageous to host survival because it would be ex-
pected to provide abundant cytosolic antigen to stimulate
CD8+ T cell-mediated immunity.
The role of different DC subsets in Lm pathogenesis and anti-
gen presentation is a key question that is difficult to address be-
cause current methods for DC ablation, such as the CD11c-DTR
system, deplete all CD11c+ DCs, as well as splenic macro-
phages (Probst et al., 2005). The spleen contains two main
DCs subsets, CD8a+DEC205+ DCs, which reside in the PALS
and bridging channel (Steinman et al., 1997) and present MHC
I bound peptides more efficiently (Dudziak et al., 2007), and
CD8a, 33D1+ DCs found primarily in the RP and MZ (Steinman
et al., 1997), which present antigen to CD4+ T cells preferentially.
Neuenhahn et al. (2006) observed CD8a+ DCs in the MZ and RP
where they would have direct contact with Lm entering the
spleen. Although CD8a+ DCs were shown to preferentially con-
tain live Lm, DCs were not strictly required for antigen presenta-
tion because the adoptive transfer of infected macrophages
could restore T cell responses in mice depleted of DCs (Neuen-
hahn et al., 2006). CD8a+ DC have been shown to prime T cell re-
sponses to Lm (Belz et al., 2005), suggesting that these DCs play
a central role in stimulating Lm-specific responses. Moreover,
CD8a+ DCs are specialized for crosspresentation (den Haan
et al., 2000) and this function may be important for stimulating
T cell responses to Lm. In our study it is noteworthy that we often
found T cell clusters around infected DCs, suggesting that early
CD8+ T cell activation proceeds primarily via the classical MHC I
pathway. We did not examine MHC II antigen presentation and it
is entirely possible that different regions of the spleen and dis-
tinct APCs might be involved in activating CD4+ T cells (Odoardi
et al., 2007).
Defining the precise cellular mechanisims that deliver bacterial
antigens to the PALS is important for understanding how antigen
presentation occurs in the spleen. Recently, Cinamon et al.
(2008) showed that MZ B cells shuttle soluble antigen from the
MZ to follicles in the white pulp in a CXCR5-dependent manner.
Because the entry of Lm into the PALS is sensitive to PTx treat-
ment, bacterial transport likely involves chemokine signaling as
well. CCR7-deficient mice showed decreased T cell priming
and increased susceptibility to Lm infection (Kursar et al.,
2005). This result was attributed to the failure of T cells and
DCs to efficiently colocalize in the absence of CCR7; however,
this study did not address the impact of CCR7 deficiency on
Lm transport and antigen presentation directly. The work of
others suggests that the transport of Lm to the PALS is contin-
gent on the cytosolic entry of bacteria given that neither heat-
killed nor LLO-deficient Lm enter the host cell cytosol and both
fail to reach the PALS after i.v. challenge (Glomski et al., 2003;
Lauvau et al., 2001; Muraille et al., 2005). Importantly, these non-
cytosolic forms of Lm also fail to elicit robust T cell immunity,
suggesting a link between PALS infection and T cell priming.
As suggested by Muraille et al. (2005), a critical step in the pro-
gression of Lm infection to the PALS might be the recognitionImmunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc. 483
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tors (Mariathasan and Monack, 2007; Dufner et al., 2007; Park
et al., 2007).
There are several plausible mechanisms for Lm entry to the
PALS: migration of infected DCs from MZ to PALS, migration
of PALS DCs to the MZ boundary to capture and carry back
Lm, and cell-cell spread of Lm from MZ to PALS. The issue of
cell-cell spread has been addressed by experiments with
ActA-deficient Lm, which cannot mobilize host cell actin (Mur-
aille et al., 2005). In the presence of gentamicin, ActA-deficient
Lm can still enter the PALS, arguing that PALS infection does
not require cell-cell spread. Ideally, single-cell tracking experi-
ments with GFP-Lm and 2P microscopy will help determine
whether one or more of these mechanisms is at work.
We propose that early host-pathogen interactions in the MZ
lead to the transport of intracellular antigen to the PALS for pre-
sentation to T cells. Our results with Lm suggest that targeting
antigen delivery to the PALS might be an effective strategy to
enhance vaccine efficacy and the priming of CD8+ T cells to
intracellular pathogens.
EXPERIMENTAL PROCEDURES
Mice
BALB/cJ mice were obtained from The Jackson Laboratory. CD11c-YFPmice
(Lindquist et al., 2004) were a gift of the M. Nussenzweig lab. WP11.12 TCR
transgenic mice, expressing a transgenic TCR that recognizes p60449-457 pep-
tide in the context of H-2Kd (Mercado et al., 2000), were a gift from E. Pamer
(Sloan-Kettering Institute, NY). Mice were maintained and bred under SPF
conditions in the Washington University mouse facility.
Bacteria, Fluorescent Beads, and Dextran
The GFP-expressing Lm EGD strain was made with the pNF8 vector (Fortinea
et al., 2000). The LD50 of our GFP-expressing Lm strain was 1.13 10
5 in BALB/
c mice, or 50-fold attenuated compared with wild-type EGD. Both GFP-ex-
pressing Lm and the EGD strain were stored as frozen glycerol stocks (1 3
109/ml) at 80C. Mice were infected with Lm diluted in PBS (to indicated
doses) from frozen stocks or overnight cultures. For infection times less than
or equal to 2 hr, we typically used 107 EGD Lm. For infections at 12 and
24 hr, we used 104–105 bacteria. FluoSpheres carboxylate-modified micro-
spheres (yellow-green, 1.0 mm and 0.5 mm) and Fluorescein-conjugated dex-
tran (lysine-fixable, 500 kD) were purchased from Invitrogen. All reagents
were injected i.v. in a volume of 200 ml.
Histology
Mice were euthanized and spleens harvested and embedded in Tissue-Tek
OCT compound. 5 mmcryosections were cut and fixed with 4% paraformalde-
hyde in PBS (pH 7.2) at 4C for 5 min and then blocked with StartingBlock
Blocking Buffer (PIERCE) for 10 min before being sequentially incubated
with fluorescent dye-conjugated or biotin-conjugated primary antibodies
(1:100 dilution with blocking buffer), fluorescent dye-conjugated secondary
antibodies and/or fluorescent dye-conjugated streptavidin (1:100 dilution
with blocking buffer). Sections were mounted in GVA mount (Invitrogen) and
stored at 4C. Details for antibodies and reagents used for immunofluores-
cence staining can be found in the Supplemental Data.
Immunofluorescence Microscopy
Four-color fluorescence microscopy of cryosections was performed with an
Olympus BX51 equipped with 100W mercury lamp (Olympus) and a SPOT
RT CCD camera (Diagnostic Instruments). Monochrome images (1200 pix 3
1600 pix = 8853 1180 mmwith 103 objective; 4403 586 mmwith 203 objec-
tive, 12-bit depth) were acquired through fluorescence filters optimized for
DAPI, FITC, TRITC, and Cy5 (Chroma). Images were acquired, processed to
reduce background, pseudo-colored, andmerged with SPOT RT camera soft-484 Immunity 29, 476–486, September 19, 2008 ª2008 Elsevier Inc.ware. Immunofluorescence images were segmented into splenic compart-
ments and the number of pixels specific for Lm staining or fluorescent beads
was measured and expressed as the percentage of pixels in each compart-
ment (see Supplemental Data for details).
Pertussis Toxin and Clodronate Liposome Treatment
PTx was purchased from Sigma (St. Louis, MO). Mice were injected with 500
ng of PTx i.p. 1 day prior to infection (107 for 0.5 hr and 105 for 24 hr) and Lm
tissue distribution was assessed by immunofluorescence at 0.5 and 24 hr later.
In other experiments, the survival of PTx-treated mice after Lm infection with
103 CFU of EGD (LD50 2 3 103 in BALB/C mice) was determined. In 2P ex-
periments, mice were given 500 ng PTx i.p. 1 day before to the transfer of fluo-
rescently labeled Lm-specific and polyclonal T cells. T cells were allowed to
home for several hours and then mice were infected by an i.v. injection of
Lm (104 for EGD or 105 GFP-Lm). Approximately 9 hr later, spleen explants
were cut and imaged with 2P microscopy and T cell behaviors (velocity and
clustering) analyzed. In some experiments, PTx was administered 8–9 hr after
infection to allow Lm time to enter the PALS. T cells were adoptively trans-
ferred 1–2 hr later and T cell behaviors analyzed with 2P microscopy for
changes in motility and clustering beginning at 2 hr after T cell transfer.
For depletion of phagocytes, clodronate liposome suspensions were pre-
pared as described previously (Calderon et al., 2006; van Rooijen and van Kes-
teren-Hendrikx, 2003). Mice were given 200 ml of clodronate liposome suspen-
sion i.v. 2 or 6 days before infection. The depletion of macrophages and
dendritic cells was assessed on day 2 and day 6 by staining sections for
MARCO, MOMA-1, CD11b, and CD11c. Spleens were examined by immuno-
fluorescence microscopy 24 hr after infection to quantify the amount of Lm in
the MZ, RP, and PALS regions. Similar depletion and recovery experiments
were preformed with the CD11c-DTR system of Jung et al. (Jung et al.,
2002; Probst et al., 2005).
Two-Photon Microscopy
CD8+ T cells were purified by negative selection with magnetic beads (Miltenyi
Biotec) from BALB/cJ orWP11.12mice (Mercado et al., 2000), then labeled for
30 min at 37Cwith 20–50 mMCMAC, 10 mMCFSE, or 10 mMCMTMR (Invitro-
gen). T cells (53 105–7 3 106) were resuspended in 200 ml of PBS, adoptively
transferred by tail vein injection and allowed to home for several hours before
mice were infected with 105 EGD Lm. In some experiments, we infected mice
with 106 GFP-expressing Lm to localize bacteria and T cell clusters in 3D
space. Explanted spleens were secured to coverslips with a thin film of
VetBond (3M). To image the WP, spleens were cut longitudinally with a vibra-
tome (Pelco). Spleen sections were placed in a flow chamber and maintained
at 37C by perfusion with warm, high-glucose DMEM bubbled with a mixture
of 95% O2 and 5% CO2. Time-lapse imaging was performed with a custom-
built two-photon microscope, fitted with two Chameleon Ti:sapphire lasers
(Coherent) and an Olympus XLUMPlanFI 203 objective (water immersed; nu-
merical aperture, 0.95) and controlled and acquired with ImageWarp (A&B
software). For imaging of GFP, the excitation wavelength was 890–915 nm;
for CMTMR and CMAC, 780–800 nm was used. Signals from fluorescent
dyes and GFP were separated by dichroic mirrors (490 nm, 515 nm, and 560
nm). To create time-lapse sequences, we typically scanned volumes of tissue
1003 1203 75 mmwith 31 Z-steps of 2.5 mmeach at 30–45 s intervals for up to
60 min.
CFSE T Cell Proliferation Assay
Purified 5–7 3 106 WP11.12 T cells were labeled with CFSE (5 mM) and trans-
ferred to recipient mice 2 hr before Lm infection (104). PTx-treated mice were
given 500 ng of PTx i.p. 24 hr prior to infection with Lm (104 and 5 3 104). Be-
ginning at 24 hr after infection, mice were given ampicillin (5 mg/ml in drinking
water) to eliminate bacteria. On day 3 of infection, CFSE dilution was assessed
by flow cytometry (23 106 cells) with Vb8.1 to enrich for WP11.12 T cells in the
analysis.
Data Analysis
Cells were detected based on fluorescence intensity and cell tracks obtained
with Volocity (Improvision) or Imaris (Bitplane) software. Tracks greater than
3 min (R7 time points) were included in the analysis. Cell velocities were re-
ported as the median of instantaneous velocities in each cell track. Motility
Immunity
Antigen Presentation in Splenic White Pulpcoefficients (mm2 min1) were calculated for individual tracks by linear regres-
sion of displacement2 versus time plots with T Cell Analysis (John Dempster,
University of Strathclyde). Clusters were analyzed in five randomly selected
time points with PicViewer (John Dempster, University of Strathclyde) as pre-
viously described (Zinselmeyer et al., 2005).
Statistical Analysis
Non-normally distributed data were presented asmedians and compared with
theMann-WhitneyU-test (two groups) or with an ANOVA followed by a suitable
multiple comparison procedure (Dunn’s or Dunnett’s test).
SUPPLEMENTAL DATA
Supplemental Data include eight figures and seven movies and can be found
with this article online at http://www.immunity.com/cgi/content/full/29/3/476/
DC1/.
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